Dose: 0.171 to 0.714 mg/kg
Single Dose: 0.44 (0.4425)
Frequency: 24 hourly
Route: PO
Instructions: -

Dose: Not used in this age group
Single Dose:
Frequency:
Route:
Instructions:

Dose: 0.2 mg/kg
Single Dose: 0.2 (0.2)
Frequency: 24 hourly
Route: Oral
Instructions: At bed time

. It is of Synthetic origin and belongs to Pyrole. It belongs to Cholinergic muscarinic antagonist pharmacological group on the basis of mechanism of action and also classified in Gastrointestinal Anticholinergics/Antispasmodics pharmacological group.The Molecular Weight of Poldine (Methylsulphate) is 451.50.

Poldine (Methylsulphate) is contraindicated in conditions like Cardiac arrhythmia,Mania,Myocardial infarction,Heart block,Narrow-angle glaucoma,Hypersensitivity,Urinary retention.

The signs and symptoms that are produced after the acute overdosage of Poldine (Methylsulphate) include Tachycardia, Confusion, Hallucinations, Delirium, Tachypnea, Hyperpyrexia, Excitation.The symptomatic adverse reactions produced by Poldine (Methylsulphate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Tachycardia, Constipation, Dry mouth, Blurred vision, Urinary hesitancy.

Poldine (Methylsulphate) is primarily indicated in conditions like Cataplexy, Depression, Obsessive-compulsive disorders, Peptic ulcer, Phobic states, and can also be given in adjunctive therapy as an alternative drug of choice in Acne, Endocrine adenomas, Hyperhidrosis, Zollinger-ellison syndrome.

No data regarding the interactions of Poldine (Methylsulphate) was found.

Drug should not be given to Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab

No data regarding the Warnings/Precuations of Poldine (Methylsulphate) is available.